Indication
Diabetes Mellitus Type 2
7 clinical trials
13 products
3 drugs
Product
PF-07081532Clinical trial
A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Escalating Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2021-07-14
Product
ClopidogrelClinical trial
Does Glycated Hemoglobin Variability in Type 2 Diabetes Differ Depending on the Diabetes Treatment Threshold Used in the Qatari Population: Implication on Diabetes Complication Risk?Status: Active (not recruiting), Estimated PCD: 2023-10-01
Drug
MetforminProduct
GliclazideDrug
SitagliptinProduct
LiraglutideProduct
PioglitazoneDrug
DapagliflozinProduct
Human InsulinClinical trial
Clinical Protocol to Investigate the Efficacy of Amlexanox for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 DiabeticsStatus: Terminated, Estimated PCD: 2014-02-25
Product
AmlexanoxClinical trial
IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 DiabetesStatus: Recruiting, Estimated PCD: 2024-06-30
Product
AnakinraClinical trial
The Efficacy of a Single Intravitreal Injection of Bevacizumab in Patients With Diffuse Diabetic Macular EdemaStatus: Withdrawn, Estimated PCD: 2005-09-01
Product
BevacizumabClinical trial
A Pilot Study of Outpatient Discharge Therapy With Saxagliptin + Metformin XR or Sulphonylurea for Recently Diagnosed Type 2 Diabetes Presenting With Severe HyperglycemiaStatus: Completed, Estimated PCD: 2015-07-25
Product
GlipizideProduct
Saxagliptin + Metformin XRProduct
MetforminClinical trial
Improved Adipose Tissue Storage of Dietary Fatty Acids as a New Mechanism for the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric SurgeryStatus: Recruiting, Estimated PCD: 2028-01-31
Product
Nicotinic Acid